Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aripiprazole”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00046384
What this trial is testing

Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc.
Early research (Phase 1)Study completedNCT02220712
What this trial is testing

Open-label Study Investigating the Pharmacokinetics and Safety of Aripiprazole IM Depot Formulation (OPC-14597 IMD) During Repeated Administration by Injection Into the Deltoid Muscle in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Co., Ltd. 17
Post-approval studies (Phase 4)Study completedNCT00103571
What this trial is testing

Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia

Who this might be right for
Schizophrenia
Eli Lilly and Company 600
Post-approval studies (Phase 4)UnknownNCT02282085
What this trial is testing

Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia

Who this might be right for
Schizophrenia
Matt Byerly 200
Post-approval studies (Phase 4)Study completedNCT03839251
What this trial is testing

Effectiveness of Aripiprazole Long-acting Injection in Recent Onset and Chronic Schizophrenia Patients

Who this might be right for
Schizophrenia
Chonbuk National University Hospital 82
Large-scale testing (Phase 3)WithdrawnNCT00338273
What this trial is testing

Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc.
Large-scale testing (Phase 3)Study completedNCT00102063
What this trial is testing

Aripiprazole in Adolescents With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 302
Large-scale testing (Phase 3)Study completedNCT01418352
What this trial is testing

Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder (TD)

Who this might be right for
Tourette's Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 83
Large-scale testing (Phase 3)Study completedNCT01617447
What this trial is testing

A Short Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder

Who this might be right for
Autistic Disorder
Otsuka Pharmaceutical Co., Ltd. 92
Large-scale testing (Phase 3)Study completedNCT00198107
What this trial is testing

Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism

Who this might be right for
Autistic Disorder
Indiana University 81
Not applicableStudy completedNCT01795105
What this trial is testing

ABF Tourette's Disorder Post Marketing Surveillance Study

Who this might be right for
Tourette's Disorder
Korea Otsuka Pharmaceutical Co., Ltd. 692
Not applicableStudy completedNCT01185418
What this trial is testing

Evaluation of Negative Symptoms and Cognitive Function After Administration of Antipsychotics in Healthy Volunteer

Who this might be right for
Normal Volunteers
Chonbuk National University Hospital 80
Post-approval studies (Phase 4)Study completedNCT01028820
What this trial is testing

FMRI Brain Activation of Aripiprazole Treatment in Autism Spectrum Disorders

Who this might be right for
Autism Spectrum Disorder
University of North Carolina, Chapel Hill 13
Testing effectiveness (Phase 2)Study completedNCT00619190
What this trial is testing

Study of Aripiprazole to Treat Children and Adolescents With Autism

Who this might be right for
Autistic DisorderAsperger SyndromeAutism Spectrum Disorder
University of North Carolina, Chapel Hill 30
Large-scale testing (Phase 3)Ended earlyNCT03892889
What this trial is testing

A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 277
Post-approval studies (Phase 4)Study completedNCT01333072
What this trial is testing

Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART)

Who this might be right for
Autistic Disorder
Medical University of South Carolina 80
Post-approval studies (Phase 4)UnknownNCT00352339
What this trial is testing

The New Strategy for Pharmacological Treatment in People With Schizophrenia

Who this might be right for
Schizophrenia
Inje University 90
Post-approval studies (Phase 4)Study completedNCT01696617
What this trial is testing

Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Seoul National University Hospital 46
Post-approval studies (Phase 4)Study completedNCT01119014
What this trial is testing

Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis

Who this might be right for
Psychosis
Anne Katrine Pagsberg 300
Large-scale testing (Phase 3)Study completedNCT00080314
What this trial is testing

Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 400
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation